BOEHRINGER Ingelheim (BI)
has announced the launch of two
new cough products this autumn,
Bisolvon Chesty Natural which is
already on shelves and Bisolvon
Pholcodine Dry Forte which
becomes available from early May.
Bisolvon Chesty Natural Liquid
contains the active ingredient
hedera helix with lactoferrin which
the company says helps clear
mucous from the chest, calms
coughs and may help boost the
immune system against winter bugs.
This product comes in a honey
and lemon flavour and will be
nationally advertised on television.
Bisolvon Pholcodine Dry Forte
Liquid contains 4mg pholcodine,
per 1mL, which is a higher strength
liquid than the “leading dry forte
brand,” Boehringer Ingelheim says.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Apr 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Apr 16
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.